Saving changes...

Done

Error

Making a Difference in ADHD: Screening and Treating for Primary Care

Making a Difference in ADHD: Screening and Treating for Primary Care

Making a Difference in ADHD: Screening and Treating for Primary Care

National Association for Continuing Education
National Association for Continuing Education
on behalf of National Association for Continuing Education

$20.00 $ 20.00 $ 20.00

$20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Normal Price: $20.00 $20.00

Review:

Launch date: 15 Feb 2018
Expiry Date: 04 Jan 2019

Last updated: 23 Aug 2018

Reference: 187001

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Welcome to the National Association for Continuing Education monograph from the NACE Clinical Updates for NPs and PAs 2017 conference.

Despite the lingering myth that attention deficit hyperactivity disorder (ADHD) is a condition of childhood, half or more of cases persist into adulthood. Because of its pervasive effects on cognition and behavior, ADHD greatly impacts the lives of adults by damaging relationships, limiting achievement, and increasing risk for accidents, substance abuse, and criminality. Early diagnosis and treatment of adults with ADHD is essential to limiting these consequences. Unfortunately, adults with ADHD are frequently undiagnosed and untreated. Primary care clinicians play a central role in the recognition and management of ADHD in adults. In this monograph, we will review current evidence and guidelines describing the epidemiology, presentation, assessment, and management of ADHD in adults.

Objectives

Objective 1: Recognize the pervasive nature of ADHD symptoms throughout the day.
After completing this program participants should be able to recognize the pervasive nature of ADHD symptoms throughout the day.
Objective 2: Describe the physical and psychologic morbidity and mortality associated with ADHD.
After completing this program participants should be able to describe the physical and psychologic morbidity and mortality associated with ADHD.
Objective 3: Use adult ADHD assessment and treatment tools to measure residual symptoms and optimize outcomes.
After completing this program participants should be able to use adult ADHD assessment and treatment tools to measure residual symptoms and optimize outcomes.
Objective 4: Implement pharmacologic treatment to optimize symptom control throughout the day.
After completing this program participants should be able to implement pharmacologic treatment to optimize symptom control throughout the day.
National Association for Continuing Education

Author Information Play Video Bio

National Association for Continuing Education
on behalf of National Association for Continuing Education

The mission of the National Association for Continuing Education (NACE) is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to increase their knowledge, competence, and professional performance to ultimately benefit their patients' health.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.00 Credits
  • American Association of Nurse Practitioners (AANP)
  • 1.00 Hours -
    Exam Pass Rate: 70

Faculty and Disclosures

Additional Contributors

Course Directors
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Deborah Paschal, CRNP
Philadelphia, PA

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Course Reviewer
Greg Mattingly, MD
Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, MO

Conflicts Declared

Conflicts of Interest declaration by Author:

Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosures are provided below.

In the past 12 months Dr. Mattingly has served as speaker for: Allergan, Lundbeck, Merk, Otsuka, Shire, Sunovion, Takeda, and Vanda; served as consultant for: Alkermes, Allergan, Forum, Lundbeck, Merk, Otsuka, Perdue, Rhodes, Shire, Sunovion, Takeda and Vanda; done Research for: Akilii, Alcobra, Alkermes, Allergan, Boehring, Forum, Janssen, Medgenics, NLS-1 Pharma AG, Reckitt Benckiser, Shire, Sunovion, Supernus and Takeda.

Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by an independent medical educational grant from Shire.

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error